10-Q Filing

IDEXX LABORATORIES INC /DE CIK: 874716 Q1 2015

Filing Information

Form Type	10-Q
Accession Number	`0000874716-15-000009`
Period End Date	20150331
Filing Date	20150428
Fiscal Year	2015
Fiscal Period	Q1
XBRL Instance	c716-20150331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 83 Income Statement 44 Cash Flow Statement 66 Comprehensive Income 26

Balance Sheet 83 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, reserves	`AllowanceForDoubtfulAccountsReceivableCurrent`	$4.44M	USD	Point-in-time
Accounts receivable, reserves	`AllowanceForDoubtfulAccountsReceivableCurrent`	$4.31M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	120.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$322.54M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$286.20M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	120.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$182.16M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$279.06M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$139.22M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	102.26M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	101.95M	shares	Point-in-time
Deferred stock units, outstanding	`CommonStockOtherSharesOutstanding`	118,000.00	shares	Point-in-time
Accounts receivable, net of reserves of $4,440 in 2015 and $4,306 in 2014	`AccountsReceivableNetCurrent`	$152.38M	USD	Point-in-time
Accounts receivable, net of reserves of $4,440 in 2015 and $4,306 in 2014	`AccountsReceivableNetCurrent`	$196.23M	USD	Point-in-time
Deferred stock units, outstanding	`CommonStockOtherSharesOutstanding`	118,000.00	shares	Point-in-time
Inventories	`InventoryNet`	$160.34M	USD	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	54.57M	shares	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	55.46M	shares	Point-in-time
Inventories	`InventoryNet`	$173.37M	USD	Point-in-time
Deferred income tax assets	`DeferredTaxAssetsNetCurrent`	$37.69M	USD	Point-in-time
Deferred income tax assets	`DeferredTaxAssetsNetCurrent`	$36.29M	USD	Point-in-time
Other current assets, net	`OtherAssetsCurrent`	$81.64M	USD	Point-in-time
Other current assets, net	`OtherAssetsCurrent`	$86.45M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$759.40M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$808.91M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$303.59M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$309.83M	USD	Point-in-time
Goodwill	`Goodwill`	$184.45M	USD	Point-in-time
Goodwill	`Goodwill`	$176.93M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$59.91M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$65.12M	USD	Point-in-time
Other long-term assets, net	`OtherAssetsNoncurrent`	$71.65M	USD	Point-in-time
Other long-term assets, net	`OtherAssetsNoncurrent`	$75.44M	USD	Point-in-time
Total long-term assets	`AssetsNoncurrent`	$622.11M	USD	Point-in-time
Total long-term assets	`AssetsNoncurrent`	$624.81M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.43B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.38B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$44.18M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$44.74M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$177.94M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$195.35M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$549.00M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$549.50M	USD	Point-in-time
Current portion of deferred revenue	`DeferredRevenueCurrent`	$31.81M	USD	Point-in-time
Current portion of deferred revenue	`DeferredRevenueCurrent`	$31.82M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$803.45M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$820.91M	USD	Point-in-time
Deferred income tax liabilities	`DeferredTaxLiabilitiesNoncurrent`	$41.69M	USD	Point-in-time
Deferred income tax liabilities	`DeferredTaxLiabilitiesNoncurrent`	$40.11M	USD	Point-in-time
Long-term debt	`SecuredLongTermDebt`	$350.00M	USD	Point-in-time
Long-term debt	`SecuredLongTermDebt`	$500.00M	USD	Point-in-time
Long-term deferred revenue, net of current portion	`DeferredRevenueNoncurrent`	$22.35M	USD	Point-in-time
Long-term deferred revenue, net of current portion	`DeferredRevenueNoncurrent`	$21.66M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$32.36M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$31.03M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$593.49M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$445.72M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.40B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.27B	USD	Point-in-time
Commitments and Contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.10 par value per share: Authorized: 120,000 shares; Issued: 102,258 and 101,947 shares in 2015 and 2014, respectively	`CommonStockValue`	$10.23M	USD	Point-in-time
Common stock, $0.10 par value per share: Authorized: 120,000 shares; Issued: 102,258 and 101,947 shares in 2015 and 2014, respectively	`CommonStockValue`	$10.20M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$912.58M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$888.29M	USD	Point-in-time
Deferred stock units: Outstanding: 118 units in 2015 and 2014	`CommonStockOtherValueOutstanding`	$5.07M	USD	Point-in-time
Deferred stock units: Outstanding: 118 units in 2015 and 2014	`CommonStockOtherValueOutstanding`	$5.08M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.72B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.68B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-8.07M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-24.05M	USD	Point-in-time
Treasury stock, at cost: 55,462 and 54,574 shares in 2015 and 2014, respectively	`TreasuryStockValue`	$2.59B	USD	Point-in-time
Treasury stock, at cost: 55,462 and 54,574 shares in 2015 and 2014, respectively	`TreasuryStockValue`	$2.45B	USD	Point-in-time
Total IDEXX Laboratories, Inc. stockholders' equity	`StockholdersEquity`	$117.52M	USD	Point-in-time
Total IDEXX Laboratories, Inc. stockholders' equity	`StockholdersEquity`	$34.02M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$57.00K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$73.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$117.59M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$34.08M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$1.38B	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$1.43B	USD	Point-in-time

Income Statement 44 line items

Line Item	Tag	Value	Unit	Period
Product revenue	`SalesRevenueGoodsNet`	$219.39M	USD	1 Quarter
Product revenue	`SalesRevenueGoodsNet`	$232.10M	USD	1 Quarter
Service revenue	`SalesRevenueServicesNet`	$150.37M	USD	1 Quarter
Service revenue	`SalesRevenueServicesNet`	$140.81M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$382.48M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$360.20M	USD	1 Quarter
Cost of product revenue	`CostOfGoodsSold`	$78.04M	USD	1 Quarter
Cost of product revenue	`CostOfGoodsSold`	$83.37M	USD	1 Quarter
Cost of service revenue	`CostOfServices`	$83.56M	USD	1 Quarter
Cost of service revenue	`CostOfServices`	$80.06M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$166.93M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$158.11M	USD	1 Quarter
Gross profit	`GrossProfit`	$215.54M	USD	1 Quarter
Gross profit	`GrossProfit`	$202.10M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$67.85M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$75.14M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$42.60M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$41.09M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$23.11M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$25.01M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$70.05M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$72.80M	USD	1 Quarter
Interest expense	`InterestExpense`	$2.77M	USD	1 Quarter
Interest expense	`InterestExpense`	$6.30M	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$471.00K	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$425.00K	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$66.92M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$67.74M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$20.35M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$21.15M	USD	1 Quarter
Net income	`ProfitLoss`	$46.59M	USD	1 Quarter
Net income	`ProfitLoss`	$46.58M	USD	1 Quarter
Less: Net (loss) income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-16.00K	USD	1 Quarter
Less: Net (loss) income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$8.00K	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$46.59M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$46.59M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.99	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.90	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.98	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.89	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	51.62M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	47.14M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	47.76M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	52.34M	shares	1 Quarter

Cash Flow Statement 66 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$46.59M	USD	1 Quarter
Net income	`ProfitLoss`	$46.58M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$13.39M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$16.15M	USD	1 Quarter
Gain on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$33.00K	USD	1 Quarter
Gain on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$18.00K	USD	1 Quarter
Amortization on marketable securities, net	`AmortizationOfDebtDiscountPremium`	$91.00K	USD	1 Quarter
Increase (decrease) in deferred compensation liability	`IncreaseDecreaseInDeferredCompensation`	$58.00K	USD	1 Quarter
Increase (decrease) in deferred compensation liability	`IncreaseDecreaseInDeferredCompensation`	$-86.00K	USD	1 Quarter
Provision for uncollectible accounts	`ProvisionForDoubtfulAccounts`	$509.00K	USD	1 Quarter
Provision for uncollectible accounts	`ProvisionForDoubtfulAccounts`	$451.00K	USD	1 Quarter
Provision for (benefit of) deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-835.00K	USD	1 Quarter
Provision for (benefit of) deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$565.00K	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$4.11M	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$4.65M	USD	1 Quarter
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$7.71M	USD	1 Quarter
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$6.75M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$51.44M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$21.71M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$10.14M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-2.20M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-1.31M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-15.48M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-4.33M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$1.86M	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-26.23M	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-10.23M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$3.23M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$1.15M	USD	1 Quarter
Net cash (used) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-14.64M	USD	1 Quarter
Net cash (used) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$33.52M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$23.02M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.30M	USD	1 Quarter
Purchase of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$140.45M	USD	1 Quarter
Proceeds from the sale and maturities of marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$3.23M	USD	1 Quarter
Acquisitions of a businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$383.00K	USD	1 Quarter
Acquisitions of a businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$1.16M	USD	1 Quarter
Acquisition of intangible asset	`PaymentsToAcquireIntangibleAssets`	$175.00K	USD	1 Quarter
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-160.62M	USD	1 Quarter
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-12.63M	USD	1 Quarter
Borrowings on revolving credit facilities, net	`ProceedsFromRepaymentsOfOtherDebt`	$38.00M	USD	1 Quarter
Borrowings on revolving credit facilities, net	`ProceedsFromRepaymentsOfOtherDebt`	$500.00K	USD	1 Quarter
Debt issue costs	`DebtIssuanceCosts`	$-139.00K	USD	1 Quarter
Debt issue costs	`DebtIssuanceCosts`	$-90.00K	USD	1 Quarter
Payment of notes payable	`RepaymentsOfSecuredDebt`	$253.00K	USD	1 Quarter
Issuance of long term debt	`ProceedsFromIssuanceOfLongTermDebt`	$150.00M	USD	1 Quarter
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$133.65M	USD	1 Quarter
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$70.28M	USD	1 Quarter
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$10.96M	USD	1 Quarter
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$12.32M	USD	1 Quarter
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$7.71M	USD	1 Quarter
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$6.75M	USD	1 Quarter
Net cash provided (used) by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-14.96M	USD	1 Quarter
Net cash provided (used) by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$36.80M	USD	1 Quarter
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$1.22M	USD	1 Quarter
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-1.91M	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-140.38M	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$7.14M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$322.54M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$286.20M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$182.16M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$279.06M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$322.54M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$286.20M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$182.16M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$279.06M	USD	Point-in-time

Comprehensive Income 26 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$46.59M	USD	1 Quarter
Unrealized gain (loss) on investments, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$19.00K	USD	1 Quarter
Net income	`ProfitLoss`	$46.58M	USD	1 Quarter
Unrealized gain (loss) on investments, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$-32.00K	USD	1 Quarter
Unrealized gain (loss), tax expense (benefit)	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$-123.00K	USD	1 Quarter
Unrealized gain (loss), tax expense (benefit)	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$3.08M	USD	1 Quarter
Foreign currency translation adjustments	`TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease`	$1.28M	USD	1 Quarter
Reclassification adjustment for gains included in net income, tax expense	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax`	$47.00K	USD	1 Quarter
Reclassification adjustment for gains included in net income, tax expense	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax`	$1.25M	USD	1 Quarter
Foreign currency translation adjustments	`TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease`	$-20.23M	USD	1 Quarter
Unrealized gain (loss) on investments, net of tax expense (benefit) of $19 in 2015 and ($32) in 2014	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$33.00K	USD	1 Quarter
Unrealized gain (loss) on investments, net of tax expense (benefit) of $19 in 2015 and ($32) in 2014	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-54.00K	USD	1 Quarter
Unrealized gain (loss), net of tax expense (benefit) of $3,082 in 2015 and ($123) in 2014	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$-253.00K	USD	1 Quarter
Unrealized gain (loss), net of tax expense (benefit) of $3,082 in 2015 and ($123) in 2014	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$7.18M	USD	1 Quarter
Less: reclassification adjustment for gains included in net income, net of tax expense of $1,253 in 2015 and $47 in 2014	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax`	$149.00K	USD	1 Quarter
Less: reclassification adjustment for gains included in net income, net of tax expense of $1,253 in 2015 and $47 in 2014	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax`	$2.96M	USD	1 Quarter
Unrealized gain (loss) on derivative instruments	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$4.22M	USD	1 Quarter
Unrealized gain (loss) on derivative instruments	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-402.00K	USD	1 Quarter
Other comprehensive (loss) income, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$823.00K	USD	1 Quarter
Other comprehensive (loss) income, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-15.98M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$47.42M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$30.60M	USD	1 Quarter
Less: comprehensive (loss) income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$8.00K	USD	1 Quarter
Less: comprehensive (loss) income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-16.00K	USD	1 Quarter
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$30.62M	USD	1 Quarter
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$47.41M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.